These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6846460)

  • 21. Development of a test grid using Eye Movement Perimetry for screening glaucomatous visual field defects.
    Kadavath Meethal NS; Mazumdar D; Asokan R; Panday M; van der Steen J; Vermeer KA; Lemij HG; George RJ; Pel JJM
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):371-379. PubMed ID: 29282563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency distribution of early glaucomatous visual field defects.
    Henson DB; Hobley AJ
    Am J Optom Physiol Opt; 1986 Jun; 63(6):455-61. PubMed ID: 3728641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Friedmann Visual Field Analyser Mark II--technical evaluation and clinical results.
    de Boer RW; van den Berg TJ; Beintema MR; Greve EL; Höppener J; Verduin WM
    Doc Ophthalmol; 1982 Dec; 53(4):331-42. PubMed ID: 7166100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Static flicker perimetry in glaucoma and ocular hypertension.
    Feghali JG; Bocquet X; Charlier J; Odom JV
    Curr Eye Res; 1991 Mar; 10(3):205-12. PubMed ID: 2044388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semi-automated kinetic perimetry: Comparison of the Octopus 900 and Humphrey visual field analyzer 3 versus Goldmann perimetry.
    Bevers C; Blanckaert G; Van Keer K; Fils JF; Vandewalle E; Stalmans I
    Acta Ophthalmol; 2019 Jun; 97(4):e499-e505. PubMed ID: 30345638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with the Fieldmaster perimeter.
    Bobrow JC; Drews RC
    Am J Ophthalmol; 1982 Feb; 93(2):238-41. PubMed ID: 7065096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal isopter position in the peripheral visual field in goldmann kinetic perimetry.
    Niederhauser S; Mojon DS
    Ophthalmologica; 2002; 216(6):406-8. PubMed ID: 12566882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of Friedmann Visual Field Analyzer tests in primary open-angle glaucoma.
    Cox MJ; Wood IC
    Optom Vis Sci; 1993 May; 70(5):421-32. PubMed ID: 8515973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing Precision of Hodapp-Parrish-Anderson Criteria for Staging Early Glaucomatous Damage in an Ocular Hypertension Cohort: A Retrospective Study.
    Chakravarti T
    Asia Pac J Ophthalmol (Phila); 2017; 6(1):21-27. PubMed ID: 28161915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of automated suprathreshold vs quantitative threshold field examination. Impact of age and ocular status.
    Kosoko O; Sommer A; Auer C
    Arch Ophthalmol; 1986 Mar; 104(3):398-401. PubMed ID: 3954641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a blue filter in visual field analysis.
    Hugkulstone CE; Vernon SA
    Br J Ophthalmol; 1991 Mar; 75(3):155-7. PubMed ID: 2012781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual field assessment in glaucoma: comparative evaluation of manual kinetic Goldmann perimetry and automated static perimetry.
    Agarwal HC; Gulati V; Sihota R
    Indian J Ophthalmol; 2000 Dec; 48(4):301-6. PubMed ID: 11340889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Background illumination and automated perimetry.
    Klewin KM; Radius RL
    Arch Ophthalmol; 1986 Mar; 104(3):395-7. PubMed ID: 3754130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blue versus white stimuli in ocular hypertension with the Friedmann Mark 1 Visual Field Analyser.
    Hugkulstone CE; Vernon SA
    Eye (Lond); 1992; 6 ( Pt 4)():356-60. PubMed ID: 1478305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the Performance of Compass Perimetry With Humphrey Field Analyzer in Eyes With Glaucoma.
    Rao HL; Raveendran S; James V; Dasari S; Palakurthy M; Reddy HB; Pradhan ZS; Rao DA; Puttaiah NK; Devi S
    J Glaucoma; 2017 Mar; 26(3):292-297. PubMed ID: 27977480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of central and peripheral visual field properties in the optic neuritis treatment trial.
    Keltner JL; Johnson CA; Spurr JO; Beck RW
    Am J Ophthalmol; 1999 Nov; 128(5):543-53. PubMed ID: 10577521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Static and kinetic visual field testing. Reproducibility in normal volunteers.
    Parrish RK; Schiffman J; Anderson DR
    Arch Ophthalmol; 1984 Oct; 102(10):1497-502. PubMed ID: 6487115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of glaucomatous visual field defect using a screening program of Humphrey Field Analyzer.
    Hong C; Song KY; Youn DH; Park WH
    Korean J Ophthalmol; 1990 Jun; 4(1):23-5. PubMed ID: 2214247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the central visual field by the Friedmann Mark I analyzer and color vision in 85 patients with multiple sclerosis. Correlation with visual evoked potentials in 50 cases].
    Grochowicki M; Vighetto A
    J Fr Ophtalmol; 1988; 11(1):61-5. PubMed ID: 3385126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detecting early glaucomatous field defects with the size I stimulus and Statpac.
    Zalta AH; Burchfield JC
    Br J Ophthalmol; 1990 May; 74(5):289-93. PubMed ID: 2354137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.